10:04 AM EDT, 08/07/2025 (MT Newswires) -- Collegium Pharmaceutical's ( COLL ) shares were up 9% in recent Thursday trading after the company reported Q2 earnings and revenue above analyst estimates.

The company reported Q2 adjusted earnings of $1.68 per diluted share, up from $1.62 a year earlier.

Three analysts polled by FactSet expected $1.62.

Net product revenue for the quarter ended June 30 was $188 million, compared with $145.3 million a year earlier.

Four analysts surveyed by FactSet expected $180.9 million.

For 2025, the company raised its net product revenue guidance to a range of $745 million to $760 million, compared with the previous outlook of $735 million to $750 million. Four analysts polled by FactSet expect $745.8 million.